162 -11 (73) 2024 - Rizaeva M.J. - THE ROLE OF PREDICTORS IN THE FORMATION OF THROMBOSIS IN ATRIAL FIBRILLATION

THE ROLE OF PREDICTORS IN THE FORMATION OF THROMBOSIS IN ATRIAL FIBRILLATION

Rizaeva M.J. - Bukhara State Medical Institute named after Abu Ali ibn Sina, Republican Scientific Center for Emergency Medical Care, Bukhara branch.

Resume

Atrial fibrillation (AF) is one of the unfavorable diseases of cardiology, because five times increases the risk of thromboembolic complications (TEC) [1]. AF is associated with a number of complications, such as cardioembolic variant of ischemic stroke (IS), worsens the quality of life, reduces exercise tolerance and increases the risk of death rate. A significant contribution to the formation of the pathogenesis of cardiac arrhythmias is played by factors associated with remodeling of the heart chambers and intracardiac hemodynamics [2].

Key words: atrial fibrillation, arrhythmia, coronary heart disease, remodeling.

First page

939

Last page

942

For citation:Rizaeva M.J. - THE ROLE OF PREDICTORS IN THE FORMATION OF THROMBOSIS IN ATRIAL FIBRILLATION//New Day in Medicine 11(73)2024 939-942 https://https://newdayworldmedicine.com/en/new_day_medicine/11-73-2024

List of References

  1. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). //European Heart Journal. 2021;42(5):373-498. doi:10.1093/eurheartj/ehaa612.
  2. Sohara H., Amitani S., Kurose M., Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: A study in patients with paroxysmal atrial fibrillation. //Journal of the American College of Cardiology. 1997;29(1):106-12.
  3. Chatterjee S, Bavishi C, Sardar P, et al. Meta-analysis of left ventricular hypertrophy and sustained arrhythmias. //Am J Cardiol. 2014;114(7):1049-52. doi:10.1016/j. amjcard.2014.07.015
  4. Заиграев И.А., Явелов И.С. Тромбоз левого предсердия и/или его ушка при неклапанной фибрилляции предсердий: частота выявления и клинические факторы риска. //Атеротромбоз. 2019;(2):68-79. https://doi.org/10.21518/2307-1109-2019-2-68-79
  5. Корнелюк И.В., Персидских Ю.А., Рабцевич В.А., Корнелюк О.М. (2015). Выбор антикоагулянтной подготовки к кардиоверсии у пациентов с персистирующей фибрилляцией предсердий с учетом эхокардиографических предикторов тромбоза ушка левого предсердия. //Медицинские новости, 2015;1(244):37-40.
  6. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation //Ann. Intern. Med. 1998;128:639-647.
  7. Хорькова Н. Ю., Гизатулина Т. П., Белокурова А. В., Горбатенко Е. А., Ярославская Е. И. (2021). Факторы тромбоэмболического риска и предикторы тромбоза ушка левого предсердия у пациентов крайнего севера с неклапанной фибрилляцией предсердий. //Российский кардиологический журнал 2021;(10):100-106
  8. Hasnulin VI, Voevoda MI, Hasnulin PV, et al. Modern Approach to Arterial Hypertension in the Circumpolar and Arctic Regions. //Literature Review. Ekologiya cheloveka [Human Ecology]. 2016;3:43-51.
  9. Shurkevich NP, Vetoshkin AS, Gapon LI, et al. Chronostructure of blood pressure in shiftworkers in the Arctic polar region. “Arterial Hypertension”. 2015;21(5):500-13
  10. Shenasa M, Shenasa H, El-Sherif N. Left ventricular hypertrophy and arrhythmogenesis. //Card Electrophysiol Clin. 2015;7(2):207-20. doi:10.1016/j.ccep.2015.03.017
  11. Zapesochnaya IL, Avtandilov AG. Five-year dynamics of circadian blood pressure profile in Far North workers with arterial hypertension. //Russ J Cardiol. 2013;(6):48-53.
  12. Boyd AC, McKay T, Nasibi S, et al. Left ventricular mass predicts left atrial appendage thrombus in persistent atrial fibrillation. //Eur Heart J Cardiovasc Imaging. 2013;14(3):269-75. doi:10.1093/ehjci/jes153.
  13. Hong-ling Yang, Yong-Ping Lin, Yan Long, Qing-ling Ma, Cheng Zhou. Predicting cardioembolic stroke with the B-type natriuretic peptide test: a systematic review and meta-analysis. //J Stroke Cerebrovasc Dis. 2014;23(7):1882-1889. doi: 10.1016/j.jstrokecerebrovasdis.2014.02.014.
  14. Pant R., Patel M., Garcia-Sayan E., Wassouf M., D’Silva O., Kehoe R.F., Doukky R. Impact of B-type natriuretic peptide level on the risk of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation: a prospective study. //Cardiovasc Ultrasound. 2015;14:4. doi: 10.1186/s12947-016-0047-6
  15. Kawabata M., Goya M., Sasaki T., Maeda S., Shirai Y., Yoshitake T. et al. Left atrial appendage thrombi formation in Japanese non-valvular atrial fibrillation patients during anticoagulation therapy – Warfarin vs. Direct Oral Anticoagulants. //Circ J. 2017;81(5):645-651. doi: 10.1253/circj.CJ-16-1089
  16. Ochiumi Y., Kagawa E., Kato M., Sasaki S., Nakano Y., Itakura K. et al. Usefulness of brain natriuretic peptide for predicting left atrial appendage thrombus in patients with unanticoagulated nonvalvular persistent atrial fibrillation. //J Arrhythm. 2015;31:307-312. doi: 10.1016/j.joa.2015.04.002.
  17. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular Imaging. //Eur Heart J Cardiovasc Imaging. 2016;17(4):412. doi: 10.1093/ehjci/jew041.
  18. Mancia G., Fagard R., Narkiewicz K., Redán J., Zanchetti A., Böhm M. et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. //J Hypertens. 2013;31(10):1925-1238. doi: 10.1097/ HJH.0b013e328364ca4c.
  19. Rizaeva M.Z. (2022). The clinical course of atrial fibrillation in patients with coronary heart disease. //European journal of molecular medicine, 2022;2(1).

    file

    download